Search results
PROMOTED
Author(s):
Nicolas M Van Mieghem
,
Kendra J Grubb
,
David Hildick-Smith
,
et al
Start date:
Mar 26, 2024
Author(s):
Matthias Brunn
,
Isabelle Durand-Zaleski
Added:
3 years ago
A Primer on Health Economics
The objective of this technical paper is to provide a user-friendly primer on economic evaluation applied to aortic valve replacement. We will firstly present the general concepts of economic evaluation with a specific focus on the reasons why the results of academic research may not be relevant to the physicians in charge of managing a department or to hospital…
View more
Author(s):
Florian Hecker
,
Mani Arsalan
,
Thomas Walther
Added:
3 years ago
Transcatheter aortic valve replacement (TAVR) has become the default treatment option for high-risk patients with aortic stenosis (AS) and, based on heart team discussion, an alternative to surgical aortic valve replacement (SAVR) in intermediate-risk patients.
TAVR has led to a paradigm shift in the basic therapeutic principle to treat AS: calcifications, in some patients quite excessive, are…
View more
Transcatheter Aortic Valve Implantation for Severe Aortic Stenosis - Overcoming the Challenges
Author(s):
Thomas Walther
,
Johannes Blumenstein
Added:
3 years ago
Article
Author(s):
Alia Noorani
,
Vinayak Bapat
Added:
3 years ago
Transcatheter aortic valve implantation (TAVI) is an established alternative to surgical valve replacement in the management of calcified severe aortic stenosis in those with co-morbidities or adverse features (advanced age, impaired left ventricular function), or in those where open surgery may be associated with unfavourable technical features, such as previous sternotomy with a patent internal…
View more
Martin B Leon
Research Area(s) / Expertise:
Author
Expertise
Author(s):
John Jose
,
Gert Richardt
,
Mohamed Abdel-Wahab
Added:
3 years ago
Transcatheter aortic valve implantation (TAVI) has undergone tremendous technological advancements since the first successful implantation in 2002 for symptomatic severe aortic valve stenosis (AS).1 It is currently considered as the standard of care for severe AS patients who have high surgical risk or may be deemed unsuitable for surgery.2 Broadly, there are two main categories of transcatheter…
View more
Foreword
Author(s):
Samin K Sharma
Added:
3 years ago
Article
Author(s):
Simon Kennon
,
Andrew Archbold
Added:
3 years ago
Patients with severe aortic stenosis who require non-cardiac surgery (NCS) present a difficult clinical problem. It is well established that their rate of postoperative cardiovascular complications is increased in comparison with patients without aortic stenosis,1–3 yet their optimal management remains uncertain. Reported prevalence rates for severe aortic stenosis range from 3.4 % in subjects…
View more
Foreword
Author(s):
Jeffrey W Moses
Added:
3 years ago
Article